BOPW
REGN icon

Brandywine Oak Private Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

Brandywine Oak Private Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-195
Closed -$205K – 242
2024
Q3 		$205K Hold
195
– – 0.02% 232
2024
Q2 		$205K Buy
+195
New +$189K 0.02% 223
2023
Q2 		– Sell
-252
Closed -$207K – 252
2023
Q1 		$207K Buy
+252
New +$190K 0.02% 243
2022
Q4 		– Sell
-380
Closed -$261K – 286
2022
Q3 		$261K Sell
380
-3
-0.8% -$1.89K 0.04% 224
2022
Q2 		$226K Sell
383
-66
-15% -$42.9K 0.03% 291
2022
Q1 		$313K Sell
449
-2
-0.4% -$1.26K 0.04% 249
2021
Q4 		$284K Sell
451
-37
-8% -$22.7K 0.03% 260
2021
Q3 		$295K Buy
+488
New +$303K 0.03% 258

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return